Bertrand Lebouche
Overview
Explore the profile of Bertrand Lebouche including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
137
Citations
1321
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Isnard S, Mabanga T, Royston L, Berini C, Bu S, Aiyana O, et al.
Front Immunol
. 2025 Jan;
15():1505752.
PMID: 39835130
Background: Factors leading to severe COVID-19 remain partially known. New biomarkers predicting COVID-19 severity that are also causally involved in disease pathogenesis could improve patient management and contribute to the...
2.
Engler K, Lessard D, Lacombe K, Palich R, Lebouche B
BMJ Open
. 2025 Jan;
15(1):e088822.
PMID: 39819929
Introduction: There is international interest in using patient-reported outcome measures in HIV care to improve the well-being of people with HIV, but the prioritisation of specific outcomes and measures remains...
3.
Avallone F, Marbaniang I, Engler K, Cox J, Lebouche B, Hickson F
J Sex Res
. 2024 Dec;
:1-9.
PMID: 39692294
Chemsex, a form of sexualized drug use, is prevalent among men who have sex with men (MSM) in the United Kingdom (UK), contributing to public health concerns like increased HIV...
4.
Ma Y, Lessard D, Vicente S, Engler K, Rodriguez Cruz A, Laymouna M, et al.
J Particip Med
. 2024 Dec;
16:e48194.
PMID: 39631058
Background: The COVID-19 pandemic was an unprecedent challenge to public health systems, with 95% of cases in Quebec sent home for self-isolation. To ensure continuous care, we implemented an intervention...
5.
Kronfli N, Mambro A, Riback L, Ortiz-Paredes D, Dussault C, Chalifoux S, et al.
Int J Drug Policy
. 2024 Oct;
133:104624.
PMID: 39426103
Background: Patient navigation increases linkage to hepatitis C virus (HCV) care following release from prison; however, little is known about the services patient navigators should provide to maximize linkage to...
6.
Kudrina I, Page M, Choiniere M, Shir Y, Eisenberg M, Ben-Sasson M, et al.
BMJ Open
. 2024 Oct;
14(10):e083791.
PMID: 39414287
Introduction: Millions of persons with chronic pain across North America and Europe use opioids. While the immunosuppressive properties of opioids are associated with risks of infections, these outcomes could be...
7.
Attieh R, Pomey M, Lebouche B, Ma Y, Hijal T, Poder T
J Prim Care Community Health
. 2024 Oct;
15:21501319241271190.
PMID: 39405442
Background: Telemonitoring for COVID-19 has gained much attention due to its potential in reducing morbidity, healthcare utilization, and costs. However, its benefit with regard to economic outcomes has yet to...
8.
Ma Y, Achiche S, Tu G, Vicente S, Lessard D, Engler K, et al.
HIV Med
. 2024 Oct;
26(2):184-206.
PMID: 39390632
Background: We developed MARVIN, an artificial intelligence (AI)-based chatbot that provides 24/7 expert-validated information on self-management-related topics for people with HIV. This study assessed (1) the feasibility of using MARVIN,...
9.
Wang Z, Zhao X, Shen H, Wang H, Cheng G, Gao Y, et al.
Health Care Sci
. 2024 Sep;
3(4):238-248.
PMID: 39220432
Purpose: Strong primary health care (PHC) systems require well-established PHC education systems to enhance the skills of general practitioners (GPs). However, the literature on the experiences of international collaboration in...
10.
Brenner B, Ibanescu R, Oliveira M, Margaillan G, Lebouche B, Thomas R, et al.
Viruses
. 2024 Aug;
16(8).
PMID: 39205204
Background: HIV drug resistance (HIV-DR) may jeopardize the benefit of antiretroviral therapy (ART) in treatment and prevention. This study utilized viral phylogenetics to resolve the influence of transmission networks on...